Evaluation of serum
LDHlevels in the diagnosis and inmonitoring the response to the treatment in
children with megaloblastic anaemia
Vinaya Kumar1,
Mirji G.2
1Dr. Vinaya
Kumar,Assistant Professor,2Dr. Gangadhar Mirji, Assistant Professor;
both authors are affiliated with Department of Paediatrics, S.N. Medical College,
Bagalkot, Karnataka, India.
Correspondence
Author: Dr. Gangadhar Mirji, Assistant Professor, Department
of Paediatrics, S.N. Medical College, Bagalkot, Karnataka, India. E-mail: drgangadharsm@gmail.com
Abstract
Background:
Megaloblastic anaemia is still a common and preventable cause of anaemia in
children.Invasive
procedure like bone marrow examination and expensive investigation like
estimation of serum vitamin B12 and folic acid levels are the definitive
diagnostic tools. Their non availability at peripheral centre lead to a great
deal of interest in other simple biochemical investigations like estimation of
serum LDH levels.Design/methods:
Children aged between 6 months to 14 yrs with clinically suspected
megaloblastic anaemia formed the study group. A detailed clinical history and examination
was done.All subjects had complete blood counts. Serum LDH levels, serum levels
of vitamin B12 and folic acid levels were done. Serial measurements of serum
LDH levels were done on day 14 and day 30 of treatment and were correlated with
the haemoglobin and MCV levels.Results:A
total of 48 patients formed the study group. All cases were anaemic with mean
HB level of 5.25g/dl, mean MCV was 100.15fl. All cases had megaloblastic
changes on peripheral smear.42 cases had low vitamin B12 levels and 6 cases had
low folic acid levels. Serum LDH levels were elevated in all cases with mean
level of 3423 IU/L. There was a significant negative correlation between HB
levels and serum LDH levels (r = -.923, p<0.001) a significant positive
correlation between MCV and serum LDH levels(r = +0.810, p<0.001). One month
after treatment HB levels and MCV improved (mean HB- 10.3g/dl and mean MCV-
88.3fl/l). There was also a significantly fall in the serum levels of LDH 14
days and one month after treatment (p<0.001, p<0.001 respectively). Conclusion: Serum LDH levelis an
important investigation in the diagnosis and in monitoring the response to
treatment in megaloblastic anaemia.
Keywords:
Megaloblastic
anemia, Serum LDH, Vitamin B12, Folic acid
Author Corrected: 25th May 2019 Accepted for Publication: 30th May 2019
Introduction
Megaloblastic anaemia constitutes a
considerable health problem in developing countries like India. The incidence
of megaloblastic anaemia in various part of our country is ranging from 3.1 to
71.1%[1]. Invasive
procedure like bone marrow examination and expensive investigations like
estimation of serum vitamin B12 and folic acid are the definitive diagnostic
tools. Their non availability at peripheral centre lead to great deal of
interest in other simple biochemical investigations like estimation of serum
LDH levels.
Elevation
of plasma lactate dehydrogenase concentration (LDH) is known to occur in
patients with megaloblastic anaemia. The literature on this subject is reviewed
by Hess [2] and the value of LDH estimations as a screening test in the
detection of megaloblastic anaemia is commented on by Fleming and Elliott [3].
Our
studies were carried out to provide further information on LDH levels in
megaloblastic anaemia and to evaluate the usefulness of serial estimations in
assessing the response to physiological amounts of folic acid, and thus as a
test of folic acid deficiencySince then number of workers documented the role
of serum LDH in megaloblastic anemia. Serum LDH estimation can be used as a
screening test for the diagnosis of megaloblastic anemia before performing a
bone marrowaspiration[4].
Objectives
To
evaluate the role of serum LDH level estimation in the diagnosis and in monitoring
the response to treatment in children with megaloblastic anemia.
Materials and Methods
Study type:
Prospective study
Study period:
June 2017 to May 20018
Inclusion criteria:
Children aged between 6months and 14 yrs, clinically suspected of megaloblastic
anemia.
Exclusion criteria:
Those who were anaemic due to other causes.
This
is a prospective study carried out in S N medical college between June 2017 and
May 2018. Children aged between 6 months to 14 yrs with clinically suspected
megaloblastic anaemia were selected. A detailed clinical history and thorough
physical examination was done in all cases. All cases had complete blood
counts, peripheral smear, serum LDH levels, serum levels of vitamin B12 and
folic acid done.CBC and serum LDH levels were repeated at 14days and 1 month
after the treatment. Haemoglobin levels, and MCV were correlated with serum LDH
levels before and after treatment. And serial measurements of LDH levels were
used to monitor the response to the treatment. Ethical committee clearance was
taken.
Results
A
total of 48 cases were formed the study group. Mean age was 4.1 yrs, 28 were
female and 20 were male. Mean haemoglobin level was 5.75g/dl, mean MCV level
was 100.12fl, mean serum LDH level was 3423IU/L. Peripheral smear of all the cases had
megaloblastic changes, 36 cases had macrocytic and 12 cases had dimorphic blood
picture. 42 cases had low vitamin B12 levels and 6 cases had low folic acid
levels.
Table-1: Mean Maximum and Minimum
of different variables
Parameter |
Mean |
Range (Minimum –
Maximum) |
Age (yrs) |
4.19 |
0.5
– 14 |
Hemoglobin(g/dl) |
5.725 |
2.7
– 9.6 |
MCV (fl) |
100.15 |
88.2
– 112.1 |
LDH level (IU/L) |
3423 |
1065
– 6678 |
There was a significant
negative correlation between haemoglobin and serum LDH levels before and after
treatment, and a significant positive correlation between MCV and serum LDH levels
before and after treatment.
Table-2: Correlation coefficients
and their statistical significance
There
is a positive correlation between haemoglobin and serum LDH levels and a
negative correlation between MCV and serum LDH levels.
Correlation between |
Before treatment |
After treatment |
Hb v/s serum LDH |
r
- -0.923, p - <0.001 |
r
- -0.780, p - <0.001 |
MCV v/s serum LDH |
r
- +0.810, p -<0.001 |
r
- +0.843, p - <0.001 |
Negative Correlation between
haemoglobin and serum LDH |
Positive
Correlation between MCV and serum LDH |
Figure-1:
Scatter diagram showing the correlation between serum LDH and Hemoglobin levels
and MCV
There
was a significant improvement in the haemoglobin level and MCV and a
significant fall in the serum LDH levels at 14 days and 1 month after the
treatment proven by the paired T test
Table-3: Comparison of mean levels
of Hemogobin, MCV and LDH levels before and after treatment
Haemoglobin |
Mean (SD) g/dl |
|
Before
Rx |
5.725(1.929) |
T
value - -26.47, p- <0.001 |
After
Rx |
10.319(1.133) |
|
MCV |
Mean (SD) fl |
|
Before
Rx |
100.15(6.002) |
T
value - -26.47, p- <0.001 |
After
Rx |
88.19(4.366) |
|
LDH levels |
Mean (SD) IU/L |
|
Before
Rx |
3423 |
T
value – 15.45, p- <0.001 |
After
Rx |
681 |
Statistically
significant improvement in the hemoglobin levels and MCV with treatment and
significant fall in the serum LDH levels proven with paired T test.
Serial
measurements of serum LDH levels showing fall in the levels with treatment (day
14 and one month)
Figure-2:
Response of serum LDH levels to treatment
Discussion
Megaloblastic
anaemia is a significant cause of ill health in developing countries like
India[1]. It is suggested that megaloblastic anaemia has been highly
underestimated in our country and customary practice of treating anaemia with iron
supplementation with subtherapeutic dosage of folic acid and Vit B12 may not
provide the required correction of hemoglobin [5]. It is known that marked
increase in serum LDH in megaloblastic anemia is due to intramedullary
destruction of megaloblasts and high content of LDH in megaloblast. Thus serum
LDH can provide an important clue in the diagnosis of megaloblastic anemia. The
present study was undertaken to highlight the serum LDH in diagnosis of
megalolastic anaemia diagnosed on peripheral blood smear and bone marrow
examination.
Mean
age at diagnosis was 4.17yrs, mean haemoglobin level was 5.85g/dl, mean MCV was
100.1fl and mean LDH level was 3423 IU/L. The maximum value of serum LDH was
8740 IU/L which was 30 times the normal value. Values as high as 28,125 units/L
have been reported and the serum LDH values reduced after treatment[6]. A
correlation between reticulocytosis and decreasing LDH activity, followed later
by rise in haemoglobin has been found in few studies[7,8].
Correlation
between serum LDH & Hb concentration:In megaloblastic
anemia low value of hemoglobin is associated with disproportionally greater
increase in total serum LDH level. In present study mean hemoglobin
concentration was 5.85 gm/dl ± 1.53 gm/dl. Gronvell C et al (1961) [9] also
found that there was an inverse relationship in megaloblastic anaemia i.e. low
values Hb values are associated with disproportionately greater increase in
serum LDH level. Prem Kumar M et al (2012) [10] in study showed mean Hb level
in all patients was 5.3 ± 1.69/dl. Also showed inverse relationship. Gore et al
(2015) [11] mean Hb in these study of 42 patients showed mean Hb as 5.41 ±
1.11. Serum LDH was elevated in 38 patients (90%) and showed inverse
relationship between LDH & Hb value.
Serum
LDH:In
present study mean serum LDH was 3423 IU/L. It means that, it was raised up to
10 - 20 times the upper normal limit. Hess and Gehn (1955) [12] showed that LDH
level raises 5-21 times than upper normal limit of serum LDH.
With
treatment there was a significant fall in the serum LDH, which makes it a
simple, cost effective serum marker in monitoring the treatment of
megaloblastic anemia[12]
Conclusion
LDH
levels in patients with megaloblastic anemia were raised above normal.Hence
serum LDH might be used as a screening tool before doing any other diagnostic
procedure and also there was a significant fall in the serum LDH levels with
treatment. Thus we conclude that serum LDH may have an important role in
diagnosis of megaloblastic anemia and also a cost effective tool in monitoring
the response to treatment.
First
and second author were major contributor in the collection of data, planning of
study, and compilation of data.
What this study adds to
existing knowledge: the present study recommends that in
resource limited settings, serum LDH levels can add as a complimentary
investigation to peripheral smear study in cases of megaloblastic anaemia and
can be used a investigation tool in monitoring the response to the treatment
References
How to cite this article?
Vinaya Kumar, Mirji G. Evaluation of serum LDH levels in the diagnosis and inmonitoring the response to the treatment in children with megaloblastic anaemia. Int J Pediatr Res. 2019;6 (05):217-220.doi:10.17511/ijpr.2019.i05.04